Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

TSX:DCBO - Toronto Stock Exchange - CA25609L1058 - Common Stock - Currency: CAD

60.65  -0.51 (-0.83%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCBO. DCBO was compared to 66 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make DCBO suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
In the past year DCBO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DCBO reported negative operating cash flow in multiple years.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.36%, DCBO belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
With an excellent Return On Equity value of 40.06%, DCBO belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
With an excellent Return On Invested Capital value of 25.70%, DCBO belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
Industry RankSector Rank
ROA 10.36%
ROE 40.06%
ROIC 25.7%
ROA(3y)-0.27%
ROA(5y)-4.49%
ROE(3y)0.71%
ROE(5y)-7.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

DCBO has a Profit Margin of 8.63%. This is amongst the best in the industry. DCBO outperforms 81.82% of its industry peers.
Looking at the Operating Margin, with a value of 8.14%, DCBO is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
With an excellent Gross Margin value of 80.92%, DCBO belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 8.14%
PM (TTM) 8.63%
GM 80.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y0.45%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
DCBO has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
The debt/assets ratio for DCBO is higher compared to a year ago.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 5.84 indicates that DCBO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.84, DCBO belongs to the top of the industry, outperforming 80.30% of the companies in the same industry.
The Debt to FCF ratio of DCBO is 0.08, which is an excellent value as it means it would take DCBO, only 0.08 years of fcf income to pay off all of its debts.
DCBO has a better Debt to FCF ratio (0.08) than 93.94% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
The Debt to Equity ratio of DCBO (0.01) is better than 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.08
Altman-Z 5.84
ROIC/WACC2.03
WACC12.69%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.13. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, DCBO is in line with its industry, outperforming 53.03% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO's Quick ratio of 1.13 is in line compared to the rest of the industry. DCBO outperforms 53.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1350.00% over the past year.
DCBO shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.67%.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 46.20% on average per year.
EPS 1Y (TTM)1350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)22.67%
Revenue growth 3Y42.18%
Revenue growth 5Y46.2%
Sales Q2Q%19.2%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.74% yearly.
Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.36% on average per year.
EPS Next Y716.57%
EPS Next 2Y239.33%
EPS Next 3Y152.06%
EPS Next 5Y89.74%
Revenue Next Year20.14%
Revenue Next 2Y17.16%
Revenue Next 3Y16.91%
Revenue Next 5Y24.36%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

DCBO is valuated quite expensively with a Price/Earnings ratio of 73.07.
69.70% of the companies in the same industry are more expensive than DCBO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.39. DCBO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 40.86, the valuation of DCBO can be described as expensive.
77.27% of the companies in the same industry are more expensive than DCBO, based on the Price/Forward Earnings ratio.
DCBO is valuated cheaply when we compare the Price/Forward Earnings ratio to 94.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 73.07
Fwd PE 40.86
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.63
EV/EBITDA 59.7
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
DCBO's earnings are expected to grow with 152.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y239.33%
EPS Next 3Y152.06%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (2/11/2025, 7:00:00 PM)

60.65

-0.51 (-0.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)02-28 2025-02-28/amc
Inst Owners34.77%
Inst Owner ChangeN/A
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap1.83B
Analysts81.25
Price Target56.68 (-6.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.78%
Min EPS beat(2)-25.3%
Max EPS beat(2)9.75%
EPS beat(4)3
Avg EPS beat(4)1.44%
Min EPS beat(4)-25.3%
Max EPS beat(4)20.77%
EPS beat(8)6
Avg EPS beat(8)95.3%
EPS beat(12)9
Avg EPS beat(12)121.51%
EPS beat(16)11
Avg EPS beat(16)74.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)0.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.8%
Revenue beat(12)1
Avg Revenue beat(12)-1.16%
Revenue beat(16)5
Avg Revenue beat(16)0%
PT rev (1m)0.54%
PT rev (3m)3.67%
EPS NQ rev (1m)-0.53%
EPS NQ rev (3m)-4.08%
EPS NY rev (1m)13.46%
EPS NY rev (3m)3.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 73.07
Fwd PE 40.86
P/S 6.12
P/FCF 51.63
P/OCF 49.23
P/B 28.41
P/tB 44.36
EV/EBITDA 59.7
EPS(TTM)0.83
EY1.37%
EPS(NY)1.48
Fwd EY2.45%
FCF(TTM)1.17
FCFY1.94%
OCF(TTM)1.23
OCFY2.03%
SpS9.91
BVpS2.14
TBVpS1.37
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.36%
ROE 40.06%
ROCE 34.54%
ROIC 25.7%
ROICexc N/A
ROICexgc N/A
OM 8.14%
PM (TTM) 8.63%
GM 80.92%
FCFM 11.85%
ROA(3y)-0.27%
ROA(5y)-4.49%
ROE(3y)0.71%
ROE(5y)-7.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y0.45%
F-Score8
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.08
Debt/EBITDA 0.02
Cap/Depr 39.28%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 129.34%
Profit Quality 137.36%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 5.84
F-Score8
WACC12.69%
ROIC/WACC2.03
Cap/Depr(3y)41.09%
Cap/Depr(5y)58.95%
Cap/Sales(3y)0.74%
Cap/Sales(5y)1.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y716.57%
EPS Next 2Y239.33%
EPS Next 3Y152.06%
EPS Next 5Y89.74%
Revenue 1Y (TTM)22.67%
Revenue growth 3Y42.18%
Revenue growth 5Y46.2%
Sales Q2Q%19.2%
Revenue Next Year20.14%
Revenue Next 2Y17.16%
Revenue Next 3Y16.91%
Revenue Next 5Y24.36%
EBIT growth 1Y680.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1766.62%
EBIT Next 3Y216.54%
EBIT Next 5Y117.3%
FCF growth 1Y2734.54%
FCF growth 3Y60.46%
FCF growth 5YN/A
OCF growth 1Y39896.9%
OCF growth 3Y45.71%
OCF growth 5YN/A